St. John's wort: natural does not necessarily mean safe
the ONA take:
According to a study published in the journal Clinical and Experimental Pharmacology and Physiology, researchers in Australia have found that adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
"It's concerning to see such severe adverse reactions in our population, when people believe they are doing something proactive for their health with little risk," lead researcher Claire Hoban, of the University of Adelaide, said in a university news release.
The study showed that side effects associated with St. John's wort use included anxiety, dizziness, hypertension, nausea, and panic attacks. The authors of the study that many patients taking St. John's wort may not be aware that they are at risk for certain adverse reactions. Patients should be advised to visit a health care professional for treatment of depression rather than self-treating with natural remedies.
St. John's wort is a popular herbal product used to treat depression in some patients. It is also known to be involved in several drug-drug interactions, particularly with oral contraceptives, anticoagulants, and some anti-cancer drugs.
Adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|